Evaluation of the Montreal Cognitive Assessment as a screening tool for cognitive dysfunction in SLE
Objectives Cognitive dysfunction in SLE is common and associated with significant morbidity but is currently underdetected. Early detection requires the use of screening tests, as formal diagnostic cognitive testing is time-consuming. This study aims to evaluate the Montreal Cognitive Assessment (Mo...
Saved in:
| Main Authors: | Eric Morand, Alberta Hoi, Sudha Raghunath, Julie C Stout, Yifat Glikmann-Johnston |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2021-04-01
|
| Series: | Lupus Science and Medicine |
| Online Access: | https://lupus.bmj.com/content/8/1/e000580.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The concordance between the Montreal Cognitive Assessment and the Repeatable Battery for the Assessment of Neuropsychological Status as a cognitive screening tool in a South African community sample
by: Sharain Suliman, et al. -
Screening of cognitive impairment in patients with Parkinson's disease: diagnostic validity of the Brazilian versions of the Montreal Cognitive Assessment and the Addenbrooke's Cognitive Examination-Revised
by: Emmanuelle Sobreira, et al.
Published: (2015-11-01) -
Montreal cognitive assessment as a cognitive outcome measure in progressive supranuclear palsy
by: Vanessa Ibrahim, et al.
Published: (2024-12-01) -
Montreal Cognitive Assessment (MoCA) use in general practice for the early detection of cognitive impairment: a feasibility study
by: Cassandre Carton, et al.
Published: (2025-04-01) -
Altered structural and functional homotopic connectivity associated with cognitive changes in SLE
by: Chunlei Li, et al.
Published: (2024-10-01)